WO2001088164A1 - Elimination inductible de sequences d'adn dans des plantes - Google Patents
Elimination inductible de sequences d'adn dans des plantes Download PDFInfo
- Publication number
- WO2001088164A1 WO2001088164A1 PCT/DE2001/000780 DE0100780W WO0188164A1 WO 2001088164 A1 WO2001088164 A1 WO 2001088164A1 DE 0100780 W DE0100780 W DE 0100780W WO 0188164 A1 WO0188164 A1 WO 0188164A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lbd
- rec
- gene
- dna sequence
- protein
- Prior art date
Links
- 108091028043 Nucleic acid sequence Proteins 0.000 title claims abstract description 65
- 230000001939 inductive effect Effects 0.000 title claims abstract description 41
- 230000008030 elimination Effects 0.000 title claims abstract description 14
- 238000003379 elimination reaction Methods 0.000 title claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 91
- 238000000034 method Methods 0.000 claims abstract description 53
- 108010091086 Recombinases Proteins 0.000 claims abstract description 35
- 102000018120 Recombinases Human genes 0.000 claims abstract description 31
- 239000013598 vector Substances 0.000 claims abstract description 31
- 230000009261 transgenic effect Effects 0.000 claims abstract description 30
- 239000003446 ligand Substances 0.000 claims abstract description 26
- 239000003550 marker Substances 0.000 claims abstract description 20
- 238000013518 transcription Methods 0.000 claims abstract description 16
- 230000035897 transcription Effects 0.000 claims abstract description 16
- 108020001507 fusion proteins Proteins 0.000 claims abstract description 12
- 102000037865 fusion proteins Human genes 0.000 claims abstract description 12
- 230000004913 activation Effects 0.000 claims abstract description 11
- 108020001756 ligand binding domains Proteins 0.000 claims abstract description 7
- 238000013519 translation Methods 0.000 claims abstract description 7
- 241000196324 Embryophyta Species 0.000 claims description 83
- 102000004169 proteins and genes Human genes 0.000 claims description 32
- 108020004414 DNA Proteins 0.000 claims description 31
- 210000004027 cell Anatomy 0.000 claims description 29
- 230000006798 recombination Effects 0.000 claims description 29
- 238000005215 recombination Methods 0.000 claims description 29
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 16
- 244000061456 Solanum tuberosum Species 0.000 claims description 13
- 210000002706 plastid Anatomy 0.000 claims description 13
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 8
- 240000008042 Zea mays Species 0.000 claims description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 6
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 5
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 5
- 235000009973 maize Nutrition 0.000 claims description 5
- 108020004511 Recombinant DNA Proteins 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 4
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 240000005979 Hordeum vulgare Species 0.000 claims description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 240000000111 Saccharum officinarum Species 0.000 claims description 3
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 3
- 235000021536 Sugar beet Nutrition 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 235000021374 legumes Nutrition 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 231100000331 toxic Toxicity 0.000 claims description 3
- 230000002588 toxic effect Effects 0.000 claims description 3
- 108050004290 Cecropin Proteins 0.000 claims description 2
- 108091026890 Coding region Proteins 0.000 claims description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 2
- 108060003100 Magainin Proteins 0.000 claims description 2
- 102000016943 Muramidase Human genes 0.000 claims description 2
- 108010014251 Muramidase Proteins 0.000 claims description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 239000005090 green fluorescent protein Substances 0.000 claims description 2
- 230000012010 growth Effects 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 239000004325 lysozyme Substances 0.000 claims description 2
- 229960000274 lysozyme Drugs 0.000 claims description 2
- 235000010335 lysozyme Nutrition 0.000 claims description 2
- 230000026326 mitochondrial transport Effects 0.000 claims description 2
- 244000061176 Nicotiana tabacum Species 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 230000000415 inactivating effect Effects 0.000 claims 1
- 239000013612 plasmid Substances 0.000 description 29
- 210000001519 tissue Anatomy 0.000 description 18
- 230000006698 induction Effects 0.000 description 14
- 230000009466 transformation Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 238000001994 activation Methods 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 230000004927 fusion Effects 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 239000012634 fragment Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 230000029087 digestion Effects 0.000 description 6
- 238000003306 harvesting Methods 0.000 description 6
- 230000002438 mitochondrial effect Effects 0.000 description 6
- 150000007523 nucleic acids Chemical class 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000014616 translation Effects 0.000 description 6
- 241000589158 Agrobacterium Species 0.000 description 5
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 239000000411 inducer Substances 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 210000003470 mitochondria Anatomy 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 241000208125 Nicotiana Species 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical group COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 210000001938 protoplast Anatomy 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 3
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 229960005309 estradiol Drugs 0.000 description 3
- 229930182833 estradiol Natural products 0.000 description 3
- 230000007721 medicinal effect Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000009827 uniform distribution Methods 0.000 description 3
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 2
- 241000219193 Brassicaceae Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 108010025815 Kanamycin Kinase Proteins 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 101710096342 Pathogenesis-related protein Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000002457 bidirectional effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000009088 enzymatic function Effects 0.000 description 2
- 238000009313 farming Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000003630 growth substance Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 229960001047 methyl salicylate Drugs 0.000 description 2
- 238000002663 nebulization Methods 0.000 description 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008635 plant growth Effects 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 229960001860 salicylate Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- 241001136782 Alca Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 101710086289 Attacin Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 102000000311 Cytosine Deaminase Human genes 0.000 description 1
- 108010080611 Cytosine Deaminase Proteins 0.000 description 1
- 102000016607 Diphtheria Toxin Human genes 0.000 description 1
- 108010053187 Diphtheria Toxin Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 101710173428 Heat shock protein 81-1 Proteins 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 241000748095 Hymenopappus filifolius Species 0.000 description 1
- 101100288095 Klebsiella pneumoniae neo gene Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 101100071586 Medicago sativa HSP18.2 gene Proteins 0.000 description 1
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- 241000208133 Nicotiana plumbaginifolia Species 0.000 description 1
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000005937 Tebufenozide Substances 0.000 description 1
- 102000006601 Thymidine Kinase Human genes 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
- 108010067973 Valinomycin Proteins 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 108091006088 activator proteins Proteins 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 101150049515 bla gene Proteins 0.000 description 1
- 150000001647 brassinosteroids Chemical class 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- FCFNRCROJUBPLU-UHFFFAOYSA-N compound M126 Natural products CC(C)C1NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC1=O FCFNRCROJUBPLU-UHFFFAOYSA-N 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 230000009454 functional inhibition Effects 0.000 description 1
- 239000007792 gaseous phase Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- -1 mellittin Proteins 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108020004017 nuclear receptors Proteins 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 231100000208 phytotoxic Toxicity 0.000 description 1
- 230000000885 phytotoxic effect Effects 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000025540 plastid localization Effects 0.000 description 1
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 1
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 1
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000007026 protein scission Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- QYPNKSZPJQQLRK-UHFFFAOYSA-N tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 244000045561 useful plants Species 0.000 description 1
- FCFNRCROJUBPLU-DNDCDFAISA-N valinomycin Chemical compound CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC1=O FCFNRCROJUBPLU-DNDCDFAISA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8237—Externally regulated expression systems
- C12N15/8238—Externally regulated expression systems chemically inducible, e.g. tetracycline
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8237—Externally regulated expression systems
Definitions
- the present invention relates to a method for the controlled elimination of a desired DNA sequence in a host organism, preferably a transgenic plant, characterized in that in step (I) the host organism with (a) the 5 'and 3' recombinations to be eliminated later DNA sequences flanked DNA sequence and (b) a ligand-binding-domain-recombinase-fusion protein (Rec-LBD) encoding these recombinant DNA sequences, which is transformed under conditions under the control of an inducible promoter to which the inducible promoter is repressed, the ligand specifically binding to Rec-LBD being absent; and in step (II) the DNA sequence to be eliminated is eliminated via the expression of Rec-LBD by activating the inducible promoter and the activation of Rec-LBD by adding the ligand which specifically binds to Rec-LBD at the desired point in time.
- step (I) the host organism with (a) the 5 'and 3' recombinations to be eliminated later DNA sequence
- the DNA sequence to be eliminated codes for a marker gene or acts as a transcription or translation stop sequence.
- the present invention also relates to the above sequences (a) and (b) containing vectors and host organisms, which are preferably transgenic plants.
- sequence-specific recombinases have been used in transgenic plants for the development of marker gene removal systems. Promoters that were inducible by chemicals were used here in particular. However, various embodiments of tetracycline-repressed or -induced promoters were found to be insufficiently suitable for reliably suppressing uncontrolled premature activation of the recombinase. However, the presence of the selectable marker gene is absolutely necessary for the selection of homogeneous, transgenic plants from the Agrobacterium-mediated transformation over a long period of time, since otherwise chimeric plants are formed, some of which are from transgenic cells and some are of non-transgenic mature ones Cells exist.
- non-transgenic cells can be sorted out via the pollen or the progeny produced by fertilization and broken down in accordance with Mendel's rules. However, this leads to a considerable Chen reduction in technical efficiency in the development of transgenic plant lines solely for marker gene removal.
- a recombinase-induced "gene switch system” can be used for "molecular farming", as has been described in principle with a tissue-specific regulated promoter. If the repression system were not controllable, the containment would not be sufficiently reliable, e.g. for the molecular farming of therapeutic proteins.
- Rec-LBD Rec-LBD
- a bidirectional constitutive promoter was used to control the gene to be activated.
- a selectable marker gene was cloned between this promoter and the gene, flanked by recombination sequences.
- the Rec-LBD system was cloned behind the free second promoter position. After induction of Rec-LBD by adding the ligand, the marker gene sequence was eliminated, the gene to be activated coming under the control of the constitutive promoter.
- the restriction to a single control system is problematic here as well, and reading through from the constitutive promoter through the marker gene into the gene to be activated can also take place.
- the invention is essentially based on the technical problem of providing an elimination system based on the Rec system for a desired DNA sequence which does not have the disadvantages of the methods described in the prior art, i.e. Above all, it ensures that the suppression of recombinase activity, as long as desired, is complete and can be achieved in a desired host organism.
- the transcription of the gene coding for the recombinase is repressed by an inducible promoter which, for example, only becomes active under anaerobic conditions.
- the gene also codes for a recombinase-LBD fusion protein which is inactivated as long as no ligand is present. Residual transcription and the residual activity of the Rec-LBD fusion protein in transgenic plants are minimized by the synergistic repression effect.
- the present invention relates to a method for the controlled elimination of a desired DNA sequence in a host organism, preferably a transgenic plant, which is characterized in that in step (I) the host organism with (a) those to be eliminated later, 5 'and 3 'DNA sequence flanked by recombination DNA sequences and (b) a ligand-binding-domain-recombinase-fusion protein (Rec-LBD) coding gene which recognizes these recombination DNA sequences and which is under the control of an inducible promoter is transformed under conditions, among which the inducible promoter is repressed, the ligand specifically binding to Rec-LBD being absent; and in step (II) the DNA sequence to be eliminated is eliminated via the expression of Rec-LBD by activating the inducible promoter and the activation of Rec-LBD by adding the ligand which specifically binds to Rec-LBD at the desired point in time.
- step (I) the host organism with (a) those to be eliminated later, 5
- Binding domain recombinase fusion protein (Rec-LBD) encoding DNA sequence under the control of an inducible promoter are both preferably inserted on a vector, the vector preferably being a plasmid, a cosmid, a virus, a bacteriophage or another vector common in genetic engineering.
- These vectors can have further functional units which bring about a stabilization of the vectors in the host organism, such as a bacterial origin of replication or the 2-micron DNA for stabilization in Saccharomyces cerevisiae.
- left border and “right border” sequences of agrobacterial T-DNA can be contained, which enables a stable integration into the genome of plants.
- a termination sequence can be present which serves to correctly terminate the transcription and to add a poly-A sequence to the transcript.
- Such elements are described in the literature (cf. Gielen et al., EMBO J. 8 (1989), 23-29) and can be interchanged as desired.
- the two DNA sequences (a) and (b) described above can also be inserted on different vectors and the host organism, preferably the transgenic plant, can be transformed simultaneously with both vectors or first with one vector and later with the other vector become.
- the DNA sequence (a) or (b) can already be integrated into the genome of the host organism and only then can the transformation be carried out with a vector containing the corresponding other DNA sequence.
- the recombinase gene is based on a virus, e.g. TMV, can lie and is only activated after infection of the host organism.
- the DNA sequence (b) can also be part of the DNA sequence (a), i.e. be inserted between the recombination DNA sequences, so that after activation the gene coding for the recombinase itself is excised.
- any recombinase system is suitable for the method according to the invention, whereby according to standard methods the person skilled in the art modifies the gene coding for the recombinase in such a way that it codes for the recombinase as a fusion protein with a ligand-binding protein or a part thereof such that the recombinase is only enzymatically active after binding of the ligand, ie the recombinase is inactive due to the fusion with the LBD in the absence of the ligand.
- ligand binding domain or "LBD” as used herein encompasses any protein or protein fragment which, after fusion to the recombinase, is capable of inhibiting recombinase activity in the absence of the ligand and restoring it after adding the ligand.
- LBD ligand binding domain
- the recombinase systems encompassed by the present invention include not only the systems already described above or in the literature, or systems modified by fusion with an LBD domain, but also systems which differ from the original systems by further modifications, as long as these do not significantly impair the use according to the invention.
- a large number of cloning vectors which contain a replication signal for E. coli and a marker gene for the selection of transformed bacterial cells are available for preparing the introduction of a foreign gene into the host organism, for example into higher plants.
- examples of such vectors are pBR322, pUC series, Ml3mp series, pACYC184, etc.
- the foreign gene can be introduced into the vector at a suitable restriction site.
- the plasmid obtained is used for the transformation of E. coli cells. Transformed E.coli cells are in a suitable medium grown, then harvested and lysed to give the plasmid. Restriction analyzes, gel electrophoresis and other biochemical-molecular biological methods are generally used as the analysis method for characterizing the plasmid DNA obtained. After each manipulation, the plasmid DNA can be cleaved and DNA fragments obtained can be linked to other DNA sequences. Each plasmid DNA sequence can be cloned in the same or different plasmids.
- a variety of techniques are available. These techniques include the transformation of plant cells with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as the transformation agent, the fusion of protoplasts, the injection, the electroporation of DNA, the introduction of DNA using the bio-listical method and other possibilities ,
- plasmids When injecting and electroporation of DNA into plant cells, there are no special requirements for the plasmids used. Simple plasmids, e.g. pUC derivatives can be used. However, if whole plants are to be regenerated from such transformed cells, a selectable marker should be present. Depending on the method of introducing desired genes into the plant cell, additional DNA sequences may be required. E.g. If the Ti or Ri plasmid is used for the transformation of the plant cell, at least the right boundary, but often the right and left boundary of the Ti and Ri plasmid T-DNA as the flank region, must be connected to the genes to be introduced.
- agrobacteria are used for the transformation, it is advantageous to clone the DNA to be introduced into special plasmids, in particular into an intermediate or a binary vector.
- the intermediate vectors can be due to sequences that are homologous to sequences in the T-DNA homologous recombination can be integrated into the Ti or Ri plasmid of the agrobacteria. This also contains the vir region necessary for the transfer of the T-DNA. Intermediate vectors cannot replicate in agrobacteria.
- the intermediate vector can be transferred to Agrobacterium tumefaciens using a helper plasmid.
- Binary vectors can replicate in both E. coli and agrobacteria.
- the agrobacterium serving as the host cell is said to contain a plasmid which carries a vir region.
- the vir region is necessary for the transfer of the T-DNA into the plant cell. Additional T-DNA may be present.
- the agrobacterium transformed in this way is used to transform plant cells.
- plant explants can expediently be cultivated with Agrobacterium tumefaciens or Agrobacterium rhizogenes.
- Agrobacterium tumefaciens or Agrobacterium rhizogenes From the infected plant material, e.g. Leaf pieces, stem segments, roots, protoplasts or suspension-cultivated plant cells can then be used to regenerate whole plants in a suitable medium, which can contain antibiotics or biocides for the selection of transformed cells.
- the plants thus obtained can then be examined for the presence of the introduced DNA.
- Other ways of introducing foreign DNA using the biolistic method or by protoplast fusion are known.
- the transgenic plants useful in the process according to the invention can in principle be plants of any plant species, i.e. both monocot and dicot plants. They are preferably useful plants, in particular plants such as wheat, barley, rice, maize, sugar beet, sugar cane, potatoes, brassicaceae, legumes or tobacco. It can also be algae, mosses and fungi.
- the parts of plants desired for the elimination of the corresponding DNA sequence in principle relate to any part of the plant, in any case propagation material and harvest products of these plants, e.g. Fruits, seeds, tubers, rhizomes, seedlings, cuttings, etc.
- the DNA sequence to be eliminated lies between a promoter and a gene and prevents the transcription and / or translation of this gene. Only after expression and activation of the recombinase is there a site-specific recombination between the two recombination DNA sequences and thus an excision of the DNA sequence to be eliminated, as a result of which the desired gene is located directly downstream of the promoter, which means the transcription and translation and thus the foreign -Protein biosynthesis initiated.
- This procedure allows, for example, use in the post-harvest production of a gene which is under the control of a very strong promoter and which codes for the desired protein to be produced.
- a protein or peptide that is toxic to the cell includes, for example, a membrane-disrupting protein or peptide, such as mellittin, magainin, cecropin, attacin, lysozyme, etc., a peptide antibiotic, such as vancomycin, valinomycin, etc., or an RNAse, in particular an RNAse without DNAse activity.
- cytosine deaminase diphtheria toxin A
- herpes simplex virus thymidine kinase type I herpes simplex virus thymidine kinase type I
- a rol protein from Agrobacterium rhizogenes an antibody against abscisic acid, etc. belong to a protein or peptide that physiologically hinders the growth of the plant.
- the method according to the invention can also be used to eliminate marker genes which were originally used for the selection of transformants and which are no longer desired in the transgenic plant at a later point in time.
- the DNA sequence to be eliminated is a selectable marker gene.
- the selectable marker gene encodes an antibiotic-inactivating protein, e.g. Neomycin phosphotransferase II, or it is a gene coding for the "green fluorescent protein".
- the method according to the invention can also be used to selectively integrate a second desired DNA sequence into the genome of the host organism after eliminating the desired DNA sequence, for example the selectable marker gene, ie instead of the eliminated DNA sequence between the 5 ' and 3 'recombination DNA sequences are introduced.
- the host organism can be transformed with a vector containing the second desired DNA sequence, so that the latter DNA sequence can specifically recombine into the genome of the host organism.
- the vectors DNA sequences and conditions suitable for this, reference is made to the above statements.
- Those skilled in the art are familiar with inducible promoters suitable for the process according to the invention and the inducers (or inhibitors) (gaseous, liquid or solid, volatile compounds) which are suitable for this purpose.
- Suitable gaseous inductors and conditions for the most efficient exchange of the gas phase are also known to the person skilled in the art. Reference is made to the anaerocult system (Merck, Darmstadt, Germany), which creates an anaerobic environment in which oxygen is bound and C0 2 is released. In this system, the GapC4 promoter from maize is induced anaerobically by the CO 2 atmosphere (Bülow, L. et al., Molecular Plant-Microbe Interactions (1999), 182-188). The same effect is also achieved by introducing technical nitrogen.
- pathogenesis related protein such as L-phenylalanine, ammonium lyase, chalcon synthase or "hydroxyproline rieh glycoprotein” promoters by ethylene (Ecker, JR and Davis, RW, Proc. Natl Acad. Sci. USA 84: 5202-5206 (1987).
- the inducible promoters suitable for the process according to the invention also include promoters which can be induced by nebulizing an inductor.
- Soluble inductors suitable for atomization and conditions for the most efficient atomization are also known to the person skilled in the art. Reference is made to a chimeric transcription induction system which is induced by the soluble inducer dexamethasone (Plant J. 11 (1997) 605-612; Kunkel et al., Nature Biotechnol. 17 (1999), 916-918 ).
- the corn incwl promoter is activated by the addition of sucrose or D-glucose (Chen, WH et al., Proc. Natl. Acad. Sci.
- the agrochemical RH5992 (Tebufenozide, Rohm & Haas, Croyden, UK) can be used for the nebulization, RH5992 acting as an inducer for the promoter to be induced via a chimeric transcription activator protein (Gatz and Lenk, Trends in Plant Science 3 (1998) , 352-358).
- the promoter is specifically turned on by RH5992 and is inactive without the presence of this compound.
- the inductor mist is flushed evenly towards the tissue to be induced, for example by a continuous air distribution.
- the effective induction of the promoter is achieved by diffusion from the tissue surface into the cells.
- Volatile inductors suitable for overflow and promoters inducible by these are likewise known to the person skilled in the art. Particularly worth mentioning is methyl salicylate, which is converted into salicylate in the receiving plant, which, as described above, has an inductive effect (Shulaev, V. et al., Supra).
- ethanol Another example of a volatile inducer is ethanol, which induces the alcA promoter from Aspergillus nidulans in transgenic tobacco (Caddick, M.X. et al., Nature Biotechnology 16 (1998), 177-180).
- the procedure is such that the liquid or solid (volatile) inductor is overflowed with a suitable gaseous carrier medium for conversion into the volatile, gaseous phase, and preferably an active circulation of the gas phase is carried out in order to achieve the uniform distribution of the inductor ,
- Suitable physically inducible promoters for example by thermal changes such as heat or cold shock, are also known to the person skilled in the art.
- To heat inducible promoters include, for example, HSP81-1 promoter from Arabidopsis thaliana (Yabe et al. Plant Cell Physiol. 35 (1994), 1207-1219) Ha hsp 18.6 G2 promoter from sunflower (Coca et al. Plant Mol. Biol. 31 (1996) 863- 876), HSP18.2 promoter from Arabidapsis thaliana in transgenic tobacco (Yoshida et al. Appl. Microbiol. Biotechnol. 44 (1995), 466-472), while the C17 promoter from potato (Kirsch et al. Plant Mol Biol. 33 (1997), 897-909) counts.
- the inducible promoter suitable for the method according to the invention is preferably an anaerobic condition, a chemical or a physically inducible promoter, such as the GapC4 promoter or the Adhl promoter, and the induction takes place via a change in the gas phase in this way that it is an oxygen deprivation; see also the explanations above.
- the anaerobically inducible GapC4 promoter (DE 195 47 272), e.g. in connection with harvested transgenic plant tissue, e.g. transgenic potato tubers.
- the DNA sequence (b) which codes for the ligand binding domain recombinase fusion protein (Rec-LBD) and is under the control of an inducible promoter is not stably integrated into the host genome, but becomes the desired one time introduced by a systemically ver ⁇ wide forming virus, for example, in the case of plants, based on TMV TMV or vectors. This approach is particularly suitable for the post-harvest production of a desired protein.
- the Rec-LBD gene can also be induced in the core of the host, e.g. of the transgenic plant cell.
- the Rec-LBD protein is fused with an N-terminal transit peptide (responsible for plastid or mitochondrial transport).
- the protein translated after induction is consequently transported into the plastids or mitochondria.
- the recombination sequences together with the DNA sequence to be eliminated later are introduced into the plastid or mitochondrial genome by direct plastid or mitochondrial transformation (for example Svab et al., Proc. Natl. Acad. Sci. USA 87) (1990), 8526-8530; Carrer et al., Mol. Gen. Genet.
- the above method is particularly suitable for post-harvest production in transformed plastids or mitochondria.
- a transcription or translation stop DNA sequence flanked by the two recombination DNA sequences is integrated between the promoter active in plastids or mitochondria and the gene to be expressed and the entire construct is integrated into the plastids or Mitochondria transformed.
- the ligand binding domain recombinase fusion protein (Rec-LBD) is N-terminal with a transit peptide fused for plastid or mitochondrial delivery and the coding DNA sequence integrated into the nuclear genome, and the gene, whose expression is to be controlled via Rec-LBD, integrated into the plastid or mitochondrial genome, whereby between the promoter for this gene and the gene even a transcription stop sequence flanked by two recombination DNA sequences is incorporated.
- Examples of these DNA encoding transit peptides are the DNA for the transit peptide of the small subunit of ribulose bisphosphate carboxylase (for plastid localization) (Anderson and Smith, Biochemical Journal 2_40 (1986), 709-715), the DNA for the Flb Subunit of ATP synthase from Nicotiana plumbaginifolia fused with maize T-urf 13 protein (Chaumont et al., Proc. Atl.Acad. Sci. USA 92 (1995), 1167-1171) and the DNA for the mitochondrial tryptophanyl-tRNA- Yeast synthetase fused with GUS (Schmitz and Londsdale, Plant Cell 1 (1989), 783-791).
- the present invention also relates to a vector which comprises (a) a DNA sequence to be eliminated, 5 'and 3' flanked by recombination DNA sequences, and (b) a ligand-binding domain-recombinase fusion protein which recognizes these recombination DNA sequences (Rec-LBD) encoding DNA sequence under the control of an inducible promoter as described above.
- a vector which comprises (a) a DNA sequence to be eliminated, 5 'and 3' flanked by recombination DNA sequences, and (b) a ligand-binding domain-recombinase fusion protein which recognizes these recombination DNA sequences (Rec-LBD) encoding DNA sequence under the control of an inducible promoter as described above.
- Rec-LBD ligand-binding domain-recombinase fusion protein which recognizes these recombination DNA sequences
- the present invention also relates to a host organism which was transformed according to step (I) of the method according to the invention or which contains the vector according to the invention.
- the host organism is preferably a host organism which was also treated in accordance with step (II) of the process according to the invention.
- the host organism is preferably a transgenic plant, the term "transgenic plant” also comprising individual parts of plants or plant organs. This also includes seeds, fruits, tubers, rhizomes, seedlings and cuttings.
- the following transgenic plants are particularly preferred: wheat, barley, maize, rice, sugar beet, sugar cane, potato, brassicaceae, legumes, tobacco, moss, algae and fungi.
- Example 1 Inducibly recombinant controlled post-harvest production of an sc-Fv antibody under the control of a strong promoter
- a synthetic nucleic acid was inserted into the Ncol restriction site of pRT100 / scFv (ox), which contained two FRT recombination sequences (Buchholz et al., Nucleic Acids Research 21 (1996), 3118-3119).
- the plasmid pRTl00 / FRT-scFv (ox) was obtained.
- the anaerobically inducible GapC4 promoter from DE 195 47 272 was modified by means of a PCR reaction in such a way that it received a HindIII restriction site at the 5 'end and an Ncol restriction site at the 3' end.
- the following primer pair was used for the PCR reaction used:
- HincII-pGapC4 Primer 5 '-CAT GTC AAC ACA TAA GGA AGA AGA
- the CaMV 35S promoter was removed from the plasmid pRTlOO by means of restriction digestion with HindIII and Ncol. Instead, the nucleic acid fragment described above was ligated in with the GapC4 promoter. The plasmid pRT10OGap was obtained.
- the cDNA coding for the FLP recombinase-LBD fusion protein (WO 95/00555) was cloned as a PCR-adapted Ncol-Xbal fragment into the Ncol site of pRT10OGap in the sense orientation. The following primer pair was used for the PCR reaction:
- NcoI-FLP-LBD Primer 5 '-CAT GCC ATG CCA CAA TTT GAT ATA TTA TGT AAA AC-3'
- FLP-LBD-Xbal Primer 5'-GCT CTA GAT CAG ACT GTG GCA GGG AAA CCC TC-3 '
- the plasmid pRT10OGap / FLP was obtained. After cleavage with HindIII, the expression cassette for the Rec-LBD protein was isolated. After filling in, this HindIII fragment was inserted "blunt end" in anti-orientation with respect to the CaMV 35S promoter and the scFv (ox) gene between the two FRT recombination sequences of the plasmid pRT100 / FRT-scFv (ox). The plasmid pRTl00 / FLP-Gap / scFv (ox) was obtained.
- the expression vector pSP 8-30 / FLP-Gap / scFv (ox) was used to transform E. coli S17-1. Transformants were mixed with Agrobacterium GV 3101 and incubated at 28 ° C overnight. (Koncz and Schell, Molecular and General Genetics 204 (1986), 383-396; Koncz. Et al., Proc. Natl. Acad. Sci. USA 94 (1987), 131-135). It was carbenicillin- lesson, the bla gene required for this was present in the above expression vectors. Selection clones of Agrobacterium tumefaciens were cut from leaves of the potato plant cv and cut several times on the middle rib.
- Desiree applied and the leaves were incubated for 2 days at 20 ° C in the dark.
- the agrobacteria were then washed off and plant growth substances were added to the potato leaves, so that shoots regenerated preferentially.
- kanamycin added to the plant medium, non-transformed cells in the potato leaves were killed.
- Growing shoots were cut off and rooted on the medium without plant growth substances, but with kanamycin (100 mg / l).
- the further cultivation of the potato plants was carried out in the usual way.
- cut leaf material or intact or cut tuber material was carried out using the Anerocult system (Merck, Darmstadt, Germany) as described in Bülow et al.
- the tubers were placed in a reaction container made of steel or plastic, which has a gas supply valve at the bottom and a gas discharge valve at the top.
- the room air in the tank became quick displaced by the supply of technical nitrogen or carbon dioxide.
- a constant composition of the gas phase in the reaction vessel was set under slow air flow (1 m 3 gas supply per hour per m 2 base area). After 40 hours, the plant material was sprayed with a solution of 10 "6 M eastern Radiol and cultured for further 2 days.
- tubers were then removed from the reaction container, homogenized, the solids content was centrifuged off and the aqueous supernatant of the chromatographic purification of the scFv In contrast to the induced, no scFv (ox) could be detected in non-induced leaf or tuber tissue.
- Example 2 Inducible marker gene removal by using the method according to the invention
- the HindIII restriction site located upstream of the GapC4 promoter was opened by partial digestion of the plasmid pRT10OGap. A synthetic nucleic acid was inserted into this interface, which contained an FRT recombination sequence (Buchholz et al., Supra) and which reconstituted the HindIII interface at the 5 'end. With a further partial HindIII digestion, the HindIII interface located downstream of the terminator was opened and a further synthetic nucleic acid was inserted which contained an FRT recombination sequence and which reconstituted the HindIII interface at the 3 ′ end. The plasmid pRTlOOGapFRT was obtained.
- the cDNA coding for the FLP recombinase-LBD fusion protein (WO 95/00555) was cloned as a PCR-adapted Ncol-Xbal fragment into the Ncol site of pRTlOOGapFRT in the sense orientation.
- the following primer pair was used for the PCR reaction:
- NcoI-FLP-LBD Primer 5 '-CAT GCC ATG CCA CAA TTT GAT ATA
- AAA CCC TC-3 The plasmid pRTlOOGapFRT / FLP was obtained.
- the expression cassette for the selectable nptII marker gene containing the CaMV 35S promoter and terminator (Odell et al., Nature 313 (1995), was converted from the plasmid pLH9000 (Hausmann and Tmür, lectures Plant Breeding 45 (1999), 155-172). 810-812) and in between the neomycin phosphotransferase II gene (nptll) (Beck et al., Gene 19 (1982), 327-336) as Xbal / Sfil fragment by restriction digestion with Xbal and Sfil.
- This expression cassette was inserted in the sense orientation into the opened Xbal site of the plasmid pRTlOOGapFRT / FLP by filling in overhanging ends after the first "sticky end” ligation step and then performing a "blunt end” ligation as the second step.
- the plasmid pRTlOOGapFRT / FLP-NPT was obtained. From this, the entire construct was isolated by restriction digestion with HindIII and inserted into the binary vector pSR 8-30.
- the expression vector pSR 8-30 / Gap-FLP-NPT was obtained, the structure of which is shown schematically in FIG. 1B.
- the potato transformation was carried out as described in Example 1.
- the anaerobic induction of the transcription of the recombinase gene was also carried out in cut sheet material on MS medium analogously to that described in Example 1.
- the activation of the FLP-LBD recombinase was carried out simultaneously by addition of 10 "6 M estradiol in the medium. Induction was carried out over a period of one week. After the induction, the sheet material was cut into small pieces and designed to shoot induction medium. Regenerated shoots were without selection 100 shoots were regenerated, which were analyzed by Southern hybridization with the nptll gene probe for elimination of the nptll gene.
- nptll gene probe 5 '-ACAACAGACAATCGGCTGC
- nptll gene was no longer present in a large number of the regenerated shoots.
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
L'invention concerne un procédé pour éliminer de manière contrôlée une séquence d'ADN voulue dans un organisme hôte, de préférence dans une plante transgénique. Ce procédé repose sur l'utilisation d'une protéine hybride « domaine de liaison du ligand-recombinase » (Rec-LBD). L'élimination de la séquence d'ADN voulue ne s'effectue qu'après expression de la Rec-LBD active par activation du promoteur inductible sous le contrôle duquel se trouve le gène codant la Rec-LBD, et par addition du ligand se fixant spécifiquement à la Rec-LBD. De préférence, la séquence d'ADN à éliminer code pour un gène marqueur ou agit en tant que séquence d'arrêt de transcription ou de translation. L'invention concerne également des vecteurs ou des organismes hôtes, de préférence des plantes transgéniques, appropriés pour ledit procédé.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001246363A AU2001246363A1 (en) | 2000-05-19 | 2001-02-28 | Inducible elimination of dna sequences in plants |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2000124740 DE10024740A1 (de) | 2000-05-19 | 2000-05-19 | Verfahren zur gesteuerten Eliminierung gewünschter DNA-Sequenzen in Wirtsorganismen |
DE10024740.7 | 2000-05-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001088164A1 true WO2001088164A1 (fr) | 2001-11-22 |
Family
ID=7642752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2001/000780 WO2001088164A1 (fr) | 2000-05-19 | 2001-02-28 | Elimination inductible de sequences d'adn dans des plantes |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001246363A1 (fr) |
DE (1) | DE10024740A1 (fr) |
WO (1) | WO2001088164A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002012474A3 (fr) * | 2000-08-03 | 2002-04-25 | Mpb Cologne Gmbh | Procede pour la selection concernant des cellules hotes a sequences d'adn eliminees |
WO2009150441A1 (fr) * | 2008-06-13 | 2009-12-17 | University Of Stavanger | Transformation mitochondriale |
CN113430210A (zh) * | 2021-06-09 | 2021-09-24 | 吉林大学 | 玉米侧器官边界蛋白基因ZmLBD24及应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995000555A1 (fr) * | 1993-06-28 | 1995-01-05 | European Molecular Biology Laboratory (Embl) | Regulation de la recombinaison a des sites specifiques par des proteines resultant de la fusion d'une recombinase a des sites specifiques et d'un recepteur nucleaire |
WO1997022707A1 (fr) * | 1995-12-19 | 1997-06-26 | Cerff Ruediger | Systeme d'expression pour l'expression genique anaerobie dans des plantes superieures |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19650714A1 (de) * | 1996-12-06 | 1998-06-10 | Melchner Harald Von Prof Dr | Genfallen-Konstrukt zur Identifizierung und Isolierung von Genen |
-
2000
- 2000-05-19 DE DE2000124740 patent/DE10024740A1/de not_active Withdrawn
-
2001
- 2001-02-28 WO PCT/DE2001/000780 patent/WO2001088164A1/fr active Application Filing
- 2001-02-28 AU AU2001246363A patent/AU2001246363A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995000555A1 (fr) * | 1993-06-28 | 1995-01-05 | European Molecular Biology Laboratory (Embl) | Regulation de la recombinaison a des sites specifiques par des proteines resultant de la fusion d'une recombinase a des sites specifiques et d'un recepteur nucleaire |
WO1997022707A1 (fr) * | 1995-12-19 | 1997-06-26 | Cerff Ruediger | Systeme d'expression pour l'expression genique anaerobie dans des plantes superieures |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002012474A3 (fr) * | 2000-08-03 | 2002-04-25 | Mpb Cologne Gmbh | Procede pour la selection concernant des cellules hotes a sequences d'adn eliminees |
WO2009150441A1 (fr) * | 2008-06-13 | 2009-12-17 | University Of Stavanger | Transformation mitochondriale |
CN113430210A (zh) * | 2021-06-09 | 2021-09-24 | 吉林大学 | 玉米侧器官边界蛋白基因ZmLBD24及应用 |
Also Published As
Publication number | Publication date |
---|---|
DE10024740A1 (de) | 2001-11-29 |
AU2001246363A1 (en) | 2001-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68929521T2 (de) | Nicht-nukleare chromosomale Transformation | |
DE69834715T2 (de) | Verfahren zur genetischer abschaltung in transgenpflanzen | |
DE69924484T2 (de) | Dsrna-bedingte regulation der gen-expression in pflanzen | |
DE69534503T2 (de) | Kontrolle der pflanzengenexpression | |
DE68915282T2 (de) | Expressionskassette für pflanzen. | |
DE60214400T2 (de) | Verfahren zur proteinproduktion in pflanzen | |
DE3843628A1 (de) | Wundinduzierbare und kartoffelknollenspezifische transkriptionale regulation | |
DD284048A5 (de) | Verfahren zur herstellung einer pflanzenzelle bzw. eines pflanzenteils oder einer pflanze mit einer derartigen pflanzenzelle | |
DE69328994T2 (de) | Verfahren zur Herstellung eines fremden Gens oder dessen Produkt in Pflanzenzellen | |
DE60032184T2 (de) | Verfahren zur verbesserung der gentransfer-effizienz in pflanzenzellen | |
WO2002012474A2 (fr) | Procede pour la selection concernant des cellules hotes a sequences d'adn eliminees | |
DE60131075T2 (de) | Durch freisetzung in geschlossener, zirkulärer form aus einer grösseren nukleotidsequenz charakterisiertes konstrukt, welches die ortsspezifische und/oder entwicklungsspezifische, regulierte expression selektierter, genetischer sequenzen erlaubt | |
WO2001088164A1 (fr) | Elimination inductible de sequences d'adn dans des plantes | |
EP1711612B1 (fr) | Cassettes d'expression permettant l'expression transgenique bidirectionnelle d'acides nucleiques chez des vegetaux | |
DE19956272B4 (de) | Verfahren zur gesteuerten Nach-Ernte-Produktion von Proteinen in Wirtsorganismen | |
EP1664307B1 (fr) | Nouveau promoteur de plante specifique de l'endosperme pour plantes cultivees | |
Saito | Genetic engineering in tissue culture of medicinal plants | |
DE10049267B4 (de) | Verfahren zur Erzeugung oder Erhöhung einer Resistenz in Organismen gegenüber biotischen Streßfaktoren | |
DE69033698T2 (de) | Gegen Glutaminsynthetaseinhibitoren resistente Sojabohnenpflanzen | |
WO1994026912A1 (fr) | Procede et vecteur recombine pour accroitre l'expression de transgenes | |
DE10133407A1 (de) | Expressionskassetten zur transgenen Expression von Nukleinsäuren | |
DE60209137T2 (de) | Verfahren zur selektion von transformierten zellen | |
WO2003041493A1 (fr) | Production d'anticorps recombines par fusion avec des peptides similaires a l'elastine | |
WO2001073085A1 (fr) | Vecteurs d'expression permettant de concentrer une proteine produite par recombinaison dans differents compartiments cellulaires | |
WO2002066661A1 (fr) | Procede pour realiser et transformer des agglomerations de mitochondries |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |